The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $153.91

Today's change-0.65 -0.42%
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $153.91

Today's change-0.65 -0.42%
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings down (U.S.)$0.65

Laboratory Corporation of America Holdings closed lower Friday, dropping (U.S.)$0.65 or 0.42% to (U.S.)$153.91. Shares have lost 1.47% over the last five days, but have gained 19.89% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $154.22
  • Previous close(U.S.) $154.56
  • High(U.S.) $154.62
  • Low(U.S.) $153.50
  • Bid / Ask-- / --
  • YTD % change+19.89%
  • Volume460,530
  • Average volume (10-day)478,362
  • Average volume (1-month)575,811
  • Average volume (3-month)696,930
  • 52-week range(U.S.) $119.51 to (U.S.) $164.22
  • Beta0.94
  • Trailing P/E21.57×
  • P/E 1 year forward16.18×
  • Forward PEG1.80×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.14
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.58%

Based on its net profit margin of 7.58%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue2,5432,4472,4282,415
Total other revenue--------
Total revenue2,5432,4472,4282,415
Gross profit862804788788
Total cost of revenue1,6811,6431,6401,626
Total operating expense2,2072,1142,1052,091
Selling / general / administrative435419406401
Research & development--------
Depreciation / amortization51484941
Interest expense (income), net operating--------
Unusual expense (income)3941023
Other operating expenses, total--------
Operating income336333323324
Interest income (expense), net non-operating-55-52-53-58
Gain (loss) on sale of assets--------
Other--------
Income before tax285280277263
Income after tax189193185180
Income tax, total96879284
Net income189192184180
Total adjustments to net income--------
Net income before extra. items189192184180
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items189192184180
Inc. avail. to common incl. extra. items189192184180
Diluted net income189192184180
Dilution adjustment--------
Diluted weighted average shares104104105105
Diluted EPS excluding extraordinary itemsvalue per share1.821.841.761.71
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share2.071.871.831.86